Publication | Closed Access

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile

VaccinationVaccine DevelopmentImmunologyVaccine TestingMicrobiologyInfection ControlMeningococcal Group BBacterial MeningitisMedicineVaccine ResearchVaccine Design